Anatomage VR Brings Interactive Anatomy Learning to The Metaverse

Anatomage Inc, a market leader in medical imaging technology, today announced the release of the Anatomage VR – a virtual reality application that gives users the opportunity to explore Anatomage’s real human bodies in the metaverse.

Imagine you have the superpower to see through the person in front of you. While looking at their body, you can peel back the skin to see their muscle and tissue. You can trace their veins and arteries moving blood throughout their body. You can fly into the chambers of the heart to experience how cardiac structures work together to make the heart beat. In the metaverse, you have this superpower with Anatomage VR.

Since the company’s inception in 2004, Anatomage has offered the most detailed, accurate and interactive human anatomy tool available with the Anatomage Table. Today, Anatomage has successfully incorporated that same flagship technology into Anatomage VR.

Designed to accompany accredited high school anatomy and life science programs, Anatomage VR grants students the power to explore the world’s most realistic human anatomy through a virtual reality headset. Anatomage VR seamlessly pairs with the Anatomage Table or can be purchased and used as a standalone product in the classroom.

With Anatomage VR, students can:

Interact with Anatomage Table’s digital bodies, including highly detailed male and female human cadavers
Visualize more than 2,500 anatomical structures in each digital body
Play 71 animated anatomy shows to inspect anatomy regions in 3D
Access, customize, and incorporate 536 presets into curriculum-focused anatomy lessons
Simulate flythroughs to travel through 10 regions of a human body endoscopically
Increase student engagement with quizzing models
Analyze real-life pathology cases with 300 real-patient CT & MRI scans
“As the world continues to embrace new virtual reality experiences, we are excited to bring Anatomage’s world-class anatomy content to the metaverse. With Anatomage VR, students can engage with anatomy learning in a never before seen way through the cutting-edge world of VR. We are so proud that our educational content is being used to teach the next generation of medical and healthcare professionals.” — Jack Choi, CEO of Anatomage

Get ready to interact with real human bodies in virtual reality through Anatomage VR.

SourceAnatomage

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”